KFx Medical Corporation has announced a new license agreement with DePuy Mitek, LLC (“Mitek”) relating to its patents used in knotless double row rotator cuff repair. Under the agreement, Mitek and its Johnson & Johnson affiliates will have the right to promote the use of products and techniques for knotless double row rotator cuff repair
KFx Medical Corporation: License Agreement with DePuy Mitek
1 min read Premium comments
Secondary
“We are proud to have our innovation recognized by Mitek. Previously we announced our licensing agreement with Smith & Nephew for the same patents. I am pleased with the licensing arrangement with these two world leaders and knowing KFx’s valuable double row knotless rotator cuff technology will reach even more patients, ” indicated Tate Scott, president and CEO in the July 24, 2014 news release.
Tate Scott told OTW, “We are pleased to reach this agreement with DePuy/Mitek, a JNJ Company. Now JNJ, along with Smith and Nephew are the only companies licensed thus far to offer the patented KFx method that provides a true anatomic-like knotless reattachment of the rotator cuff. These industry leaders already have a great deal of sales; other than that, however, I am not a liberty to disclose additional details of the agreement. I can say that KFx is in discussions with other companies regarding licenses and in litigation with Arthrex regarding this patents.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.